VC firm
Cancer Focus Fund
Also known as Cancer Focus Fund, LP
- Investor type
- VC
- Investing status
- Activeas of 2026-09-20Source (opens in a new tab)
- Headquarters
- Houston, TX, United States
- Assets under management
- $148MForm ADV private fund GAV, as of 2026-03-25Source (opens in a new tab)
- Latest fund size
- $49.7MSEC amount soldSource (opens in a new tab)
- Funds
- 6
- Legal name
- Cancer Focus Fund, LP
Claim, correct or request removal
Record updated 29 September 2026
About
We are an oncology-focused investment fund established with The University of Texas MD Anderson Cancer Center to redefine funding and support for promising cancer therapies.
Investment approach
- Thesis
- We are agnostic about where the therapies are originally developed. We scour the globe in search of the most intriguing oncology assets, and we have the right of first offer to review certain pre-IND and IND-stage therapies being considered for clinical studies at MD Anderson.Source (opens in a new tab)
- Investing status notes
- Epstein and Margolis Bring Decades of Business Expertise and Industry Leadership to Cancer Focus Fund as It Prepares for Its Next Round of Investments
Funds
- Cancer Focus Fund, LP
- $49.7MVintage 2018, Main fund, SEC amount sold
- THEMELIOS VENTURES II, L.P.
- Main fund
- TRANSBIO VENTURES, L.P.
- Main fund
- THEMELIOS VENTURES II-A, L.P.
- Main fund
- THEMELIOS VENTURES, L.P.
- Main fund
- CANCER FOCUS FUND II, LP
- Main fund
SEC registration
- Registered adviser
- BIG VENTURES MANAGEMENT COMPANY, LLC
- CRD number
- 288799 (opens in a new tab)
- SEC file number
- 802-110842
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $148Mas of 2026-03-25
- Private funds reported
- 5
- Principal office
- SHREVEPORT, LA, United States
- SEC CIK
- 1794822
Loading relationship preview